HOUSTON (August 15, 2019) – Houston-based MedSource, an award-winning full-service clinical research organization, has been ranked on Inc. magazine’s annual Inc. 5000 list for the fourth consecutive year. This adds to the company’s hall of fame status as a seven-time honoree. The ranking comes shortly after MedSource receives the 2019 CRO Leadership Awards for outstanding quality and reliability.

“The companies on this year’s Inc. 5000 have followed so many different paths to success,” says Inc. editor in chief James Ledbetter. “There’s no single course you can follow or investment you can take that will guarantee this kind of spectacular growth. But what they have in common is persistence and seizing opportunities.”

Not only have the 2019 Inc. 5000 companies been very competitive within their markets, but the list as a whole shows staggering growth compared with prior lists. The 2019 Inc. 5000 achieved an astounding three-year average growth of 454 percent, and a median rate of 157 percent. The Inc. 5000’s aggregate revenue was $237.7 billion in 2018, accounting for 1,216,308 jobs over the past three years.

“This achievement is truly a testament to the talented, committed and critically focused team here at MedSource and the clients who place their confidence in us every day,” says MedSource CEO and Founder, Eric Lund. “We strive to develop lasting relationships, provide innovative solutions, and offer flexibility while bringing the highest level of quality to the table. It is an honor to receive these awards and recognition.”

MedSource continues rapid growth that has included international expansion as well as the addition of new clinical research services to better support customer needs. The recent recognitions demonstrate that the company’s approach to clinical research is getting noticed among pharmaceutical and biotech companies using CRO services.

About MedSource

MedSource is an award winning, full-service clinical research organization (CRO) focusing on complex study designs and complex diseases with a particular expertise in oncologycentral nervous system disorders, and rare diseases. MedSource builds strong relationships with clients by serving as a trusted advisor and providing end-to-end solutions for clinical trial execution. With offices throughout North America and the United Kingdom, the company’s focus on quality, flexibility and transparency has been foundational to its growth. www.medsource.com

Media Contact
Emma Primon
Senior Marketing Manager